Cefdaloxime pentexil tosilate

N/A

Report date: 2026/04/21 20:00:18

NME

Base Information

Drug NameCefdaloxime pentexil tosilate

Drug Alias NameHR 916BHR 916KHR 916

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins

Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors

TargetsBacterial penicillin-binding protein

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A